Elizabeth Hurlburt's Insider Trades & SAST Disclosures
Elizabeth Hurlburt's most recent trade in CorMedix Inc was a trade of 5,790 Common Stock done at an average price of $11.2 . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Elizabeth Hurlburt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Elizabeth Hurlburt | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share. | 10 Jan 2025 | 5,790 | 115,728 (0%) | 0% | 11.2 | 64,790 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 87,500 | 132,897 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share. | 02 Jan 2025 | 11,378 | 121,519 (0%) | 0% | 8.2 | 93,527 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 14 Nov 2024 | 140,027 | 45,397 (0%) | 0% | 11.2 | 1,565,670 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 62,500 | 62,500 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.43 per share. | 14 Nov 2024 | 62,500 | 160,424 (0%) | 0% | 4.4 | 276,875 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 34,467 | 3,033 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 14 Nov 2024 | 34,467 | 97,924 (0%) | 0% | 4.1 | 140,625 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 25,000 | 75,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.47 per share. | 14 Nov 2024 | 25,000 | 185,424 (0%) | 0% | 3.5 | 86,750 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 9,888 | 27,612 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.63 per share. | 14 Nov 2024 | 9,888 | 63,457 (0%) | 0% | 5.6 | 55,669 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 8,169 | 12,711 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.30 per share. | 14 Nov 2024 | 8,169 | 53,569 (0%) | 0% | 8.3 | 67,803 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.33 per share. | 14 Nov 2024 | 3 | 45,400 (0%) | 0% | 1.3 | 4 | Common Stock |
| CorMedix Inc | Elizabeth Hurlburt | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 3 | 53,997 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Elizabeth Hurlburt | EVP, Head of Clinical Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy Common Stock) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges